A Proof-of-Concept Study on the Therapeutic Potential of Au Nanoparticles Radiolabeled with the Alpha-Emitter Actinium-225

Actinium-225 (²²⁵Ac) is receiving increased attention for its application in targeted radionuclide therapy, due to the short range of its emitted alpha particles in conjunction with their high linear energy transfer, which lead to the eradication of tumor cells while sparing neighboring h...

Descripció completa

Dades bibliogràfiques

Autors principals:	Evangelia-Alexandra Salvanou, Dimitris Stellas, Charalampos Tsoukalas, Barbara Mavroidi, Maria Paravatou-Petsotas, Nikolaos Kalogeropoulos, Stavros Xanthopoulos, Franck Denat, Gautier Laurent, Rana Bazzi, Stephane Roux, Penelope Bouziotis
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2020-02-01
Col·lecció:	Pharmaceutics
Matèries:	actinium-225 alpha emitters gold nanoparticles radiolabeling brachytherapy cancer therapy
Accés en línia:	https://www.mdpi.com/1999-4923/12/2/188
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!